AzTrials
AzTrials

Pregnancy RelatedNCT05440695

Undetectable Hypotension Episodes in Cesarean Section

An observational study of Pregnancy Related and Anesthesia, run by Asude AYHANt.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

In order to evaluate the efficacy and necessity of continuous non-invasive arterial pressure (CNAP) by comparing it with non-invasive blood pressure (NIBP) in order to understand whether it has advantages over oscillometric technique for detection of hypotensive episodes in healthy pregnant women who underwent… Read more about this study

Who is it for?
Ages 18 to 50 years, women only
Conditions the study is for
Pregnancy Related, Anesthesia, Blood Pressure
What is being tested?
Continuous non-invasive arterial pressure (Infinity® CNAPTM, Dräger)
How many people
53 participants
Where
No sites listed yet
Study dates
1 Feb 2014to 1 Feb 2015
Phase
Observational
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 to 50 years
  • Women only
  • No healthy volunteers
  • Adult

Study population: The study group consisted of pregnant women at term, who were scheduled for the elective (planned) C/S under spinal anesthesia in an academic tertiary care unit. Subjects were randomly assigned into 2 groups to receive either CNAP and NIBP or only NIBP.

Who may be able to join

  • Pregnant women at term, who were scheduled for the elective (planned) C/S under spinal anesthesia

Who cannot join

  • emergency C/S,
  • simultaneous gynecological interventions with C/S such as myomectomy, tubal ligation, placental abnormalities, etc.,
  • C/S that was performed in failure of labor to progress,
  • the presence of any systemic disease,
  • preeclampsia or eclampsia,
  • hypersensitivity to drugs that are used in C/S,
Show all 9Show fewer
  • multiple pregnancies,
  • pregnancies with any intrauterine fetal pathology,
  • cases with more than two missing consecutive NIBP readings.

About this study

Official title: Can We Detect Hypotension Episodes That Were Not Identified in the Non-Invasive Blood Pressure During Cesarean Section? A Randomized Controlled Trial

In order to evaluate the efficacy and necessity of continuous non-invasive arterial pressure (CNAP) by comparing it with non-invasive blood pressure (NIBP) in order to understand whether it has advantages over oscillometric technique for detection of hypotensive episodes in healthy pregnant women who underwent cesarean section (C/S) under neuraxial anesthesia. This prospective study will evaluate healthy pregnant women at term, who were scheduled for elective C/S under spinal anesthesia. Subjects were randomly assigned into 2 groups to receive either CNAP and NIBP or only NIBP. A thirty percent decrease in systolic blood pressure from either baseline or the measured values in the first two minutes, or if the systolic blood pressure was less than 90mmHg, is considered hypotension. Pre-, peri- and post-operative specifications, newborn characteristics, and complications were recorded and compared.

Read the detailed description

The aim of the study was to test the hypothesis that whether continuous non-invasive arterial pressure (CNAP) is able to identify the hypotensive episodes that were not disclosed (or identified) in the non-invasive blood pressure (NIBP), or, detects earlier compared to NIBP in healthy pregnant women who underwent C/S under neuraxial anesthesia. We also evaluated the association between monitoring CNAP vs NIBP and outcomes as a secondary endpoint.

At least 40 participants were planned to be included in each arm, considering the unforeseen technical problems (in accordance with the "Power and Sample Size Program", the inclusion of at least 29 patients was necessary for both groups for a power 0.80, alpha 0.05 and a standard deviation of 0.04).

Healthy pregnant women at term, who were scheduled for the elective C/S under spinal anesthesia in an academic tertiary care unit between February 2014 and February 2015, comprised the study group. The exclusion criteria for the study were; 1) emergency C/S, 2) simultaneous gynecological interventions with C/S such as myomectomy, tubal ligation, placental abnormalities, etc., 3) if C/S was performed in failure of labor to progress, 4) the presence of any systemic disease, 5) preeclampsia or eclampsia, 6) drug hypersensitivity - for the ones that are used in the C/S -, 7) multiple pregnancies, 8) those pregnancies with any intrauterine fetal pathology, and 9) more than two missing consecutive NIBP readings.

Subjects were randomly assigned into 2 groups to receive either CNAP and NIBP or only NIBP. CNAP finger cuff (Infinity® CNAPTM, Dräger) was used for calibrate the device before the first measurement then calibration was repeated every 30 minutes.

In the CNAP group, the CNAP finger cuff and NIBP cuff were on the same arm of the patient while the intravenous catheter was on the contralateral side. In the control group, only oscillometric NIBP measurements were done in pregnant women similar to the study group without a CNAP.

After intrathecal injection, systolic, diastolic, and mean blood pressures were measured and were recorded manually at every minute on the CNAP monitor, and the oscillometric NIBP measurements were set at the frequency of 3 minutes for the first 15 minutes, and at 5-minute intervals thereafter, and were recorded manually.

Demographic and pregnancy-related characteristics (age, parity, gravidas of the pregnant women, weeks of gestation, and the type of fertilization [spontaneous or in vitro fertilization (IVF)] were recorded.

All parturients underwent C/S after 8 hours of fasting period without any pharmacological premedication. They were monitored with 5 lead electrocardiograms, and pulse oximetry in the operating theater. By providing the monitorization, a total of 1000ml of Ringer's lactate infusion was given by an intravenous line with an 18-gauge cannula as pre-load/co-load. A 12.5 mg of hyperbaric bupivacaine was administered to all pregnant women in the left lateral decubitus position with a 26-gauge atraumatic spinal needle at the L3-4 or L4-5 interval. After the spinal injection, the patients were placed in a supine position, and the uterus was directed to the left side by using a support under the right hip. Oxygen was given to all the parturients at 3 lt / min by nasal cannula.

The block-level was assessed by loss of sensitivity to cold. When it reached the T4 skin dermatome, the surgery was started. Motor block was determined and recorded using the modified Bromage scale (0 = no block, 1 = knee flexion possible, leg unable to lift, 2 = ankle flexion and finger movements possible, unable to move the knee, 3 = full motor block in the lower extremity). The sensitivity to cold was checked every 5 minutes and the maximum block level was recorded. Analgesia was evaluated using a visual analog scale scorer (0 = no pain, 10 = most severe pain). Time from intrathecal injection to delivery (block-delivery time), time from skin incision to delivery (skin-birth time), time from uterine incision to delivery (uterus-delivery time) were recorded.

After the baby was born, the mother was sedated with midazolam 0.03 mg/kg so that the Ramsay sedation score was 2, and analgesia was provided with fentanyl 0.5 μg/kg if necessary. As the umbilical cord was clamped, 2g of cephalosporin and 5 IU of oxytocin were administered intravenously, and 15 IU oxytocin in 1000 ml Ringer's lactate was infused in an hour.

Peri/Post-Operative Periods Patients with a thirty percent decrease in systolic blood pressure from either baseline or the measured values in the first two minutes, or with systolic blood pressure less than 90mmHg; which is considered as hypotension (13), were treated with a bolus of 200 ml Ringer's lactate solution. If blood pressure did not improve after 3 minutes, 5 mg intravenous ephedrine was administered.

A decrease in heart rate below 50 beats/min was considered as bradycardia, and 0.5mg intravenous atropine was administered when encountered.

The nausea-vomiting score was calculated as follows; the absence of nausea -0, nausea without vomiting -1, and vomiting -2 points.

Patient discomfort for non-invasive blood pressure cuff and CNAP cuff scored was as 0, 1, 2, and 3 for; no discomfort, mild discomfort, moderate discomfort, and severe discomfort, respectively.

The amount of administered intravenous fluids and ephedrine during anesthesia, the umbilical artery blood gas values, and APGAR scores at 1st minute, and at 5th minutes were also recorded.

Complications, ie, postoperative fever, bleeding, need a transfusion for blood and blood products, aspiration, atelectasis, and postspinal headache, were noted at the postoperative 24th and 48th hours. The length of stay hospital stay for the mother and baby, the requirement for intensive care unit, and/or mechanical ventilator were assessed, separately.

Being tested
Continuous non-invasive arterial pressure (Infinity® CNAPTM, Dräger)
Keywords
Anesthesia, Obstetrical, Cesarean section, Arterial pressure, Blood pressure, Newborn

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Continuous non-invasive arterial pressure (Infinity® CNAPTM, Dräger)Device

    The basic working principle of CNAP is to keep the blood volume of the finger arteries constant by applying an exterior pressure to the vessel wall, that is done by an electronic system controlling the pressure inside a cuff around the finger. The pressure in the cuff, which is needed to keep the volume constant during arterial pulsation, corresponds to the AP.

Study groups in NCT05440695
Study groupRoleWhat they receive
CNAP GroupThe CNAP finger cuff and NIBP cuff were on the same arm of the patient while the intravenous catheter was on the contralateral side. After intrathecal injection, systolic, diastolic, and mean blood pressures were measured and were recorded manually at every minute on the CNAP monitor.
Receives: Device: Continuous non-invasive arterial pressure (Infinity® CNAPTM, Dräger)
NIBP GroupIn the control group, only oscillometric NIBP measurements were done in pregnant women similar to the study group without a CNAP. After intrathecal injection, systolic, diastolic, and mean blood pressures with oscillometric method were set at the frequency of 3 minutes for the first 15 minutes, and at 5-minute intervals thereafter, and were recorded manually.

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Detection of hypoptensive episodes

    Hypotensive

    Measured: Approximately 100minutes/patient (till the end of the C/S).

Secondary outcomes (17)
  1. The association between monitoring CNAP vs NIBP and other related outcomes - Anesthesia time to reach T4 level

    Anesthesia time to reach T4 level (minutes)

    Measured: Approximately 100minutes/patient (till the end of the C/S).

  2. The association between monitoring CNAP vs NIBP and other related outcomes - Skin incision time (minutes)

    Skin incision time (minutes)

    Measured: Approximately 100minutes/patient (till the end of the C/S).

  3. The association between monitoring CNAP vs NIBP and other related outcomes - Uterine incision time (minutes)

    Uterine incision time (minutes)

    Measured: Approximately 100minutes/patient (till the end of the C/S).

  4. The association between monitoring CNAP vs NIBP and other related outcomes - Time to leave the operating theater (minutes)

    Time to leave the operating theater (minutes)

    Measured: Approximately 100minutes/patient (till the end of the C/S).

  5. The association between monitoring CNAP vs NIBP and other related outcomes - Intraoperative fluid (ml)

    Intraoperative fluid (ml)

    Measured: Approximately 100minutes/patient (till the end of the C/S).

  6. The association between monitoring CNAP vs NIBP and other related outcomes - The need and amount of ephedrine used

    The need (number of patients) and amount (mg) of ephedrine used

    Measured: Approximately 100minutes/patient (till the end of the C/S).

  7. The association between monitoring CNAP vs NIBP and other related outcomes - Bolus of 200 ml Ringer's lactate solution

    The need (number of patients) of bolus 200 ml Ringer's lactate solution

    Measured: Approximately 100minutes/patient (till the end of the C/S).

  8. The association between monitoring CNAP vs NIBP and other related outcomes - Nausea

    Nausea (number of patients)

    Measured: After C/S - early postoperative period - through study completion, an average of 1 year

  9. The association between monitoring CNAP vs NIBP and other related outcomes - Vomiting

    Vomiting (number of patients)

    Measured: After C/S - early postoperative period - through study completion, an average of 1 year

  10. The association between monitoring CNAP vs NIBP and other related outcomes - Length of Hospitalization (days)

    Length of Hospitalization (days)

    Measured: Length of Hospitalization - through study completion, an average of 1 year

  11. The association between monitoring CNAP vs NIBP and other related outcomes - Cuff discomfort

    Cuff discomfort (Scale based: No - Mild - Moderate or Severe)

    Measured: Approximately 100minutes/patient (till the end of the C/S).

  12. The association between monitoring CNAP vs NIBP and other related outcomes - Newborns' Blood Gas Analysis

    Newborns' Blood Gas Analysis - Umblical Artery pH

    Measured: At the time of birth - through study completion, an average of 1 year

  13. The association between monitoring CNAP vs NIBP and other related outcomes - Newborns' Blood Gas Analysis

    Newborns' Blood Gas Analysis - Umblical Artery pO2

    Measured: At the time of birth - through study completion, an average of 1 year

  14. The association between monitoring CNAP vs NIBP and other related outcomes - Newborns' Blood Gas Analysis

    Newborns' Blood Gas Analysis - Umblical Artery pCO2

    Measured: At the time of birth - through study completion, an average of 1 year

  15. The association between monitoring CNAP vs NIBP and other related outcomes - Newborns' Blood Gas Analysis

    Newborns' Blood Gas Analysis - Umblical Artery Lactate

    Measured: At the time of birth - through study completion, an average of 1 year

  16. The association between monitoring CNAP vs NIBP and other related outcomes - Newborns' APGAR score

    Newborns' APGAR score

    Measured: After birth at 1st minute

  17. The association between monitoring CNAP vs NIBP and other related outcomes - Newborns' APGAR score

    Newborns' APGAR score

    Measured: After birth at 5th minutes

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted1 Jul 2022
  2. Study start1 Feb 2014
  3. Primary completion1 Aug 2014
  4. Study completion1 Feb 2015

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Observational
Observational model
Other
Time perspective
Prospective
Enrolment
53 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT05440695
Sponsor's protocol ID
KA13/33
Status last verified
Jun 2022
First submitted
8 Jun 2022
Last updated
1 Jul 2022
Results posted
No
Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
Yes
Individual data sharing
Yes: When the study is completed and totally shaped out as an academic manuscript, the individual participant data (IPD) will be available to other researchers.

Publications

  • Ngan Kee WD. Prevention of maternal hypotension after regional anaesthesia for caesarean section. Curr Opin Anaesthesiol. 2010 Jun;23(3):304-9. doi: 10.1097/ACO.0b013e328337ffc6.

    PubMed 20173633
  • Ilies C, Bauer M, Berg P, Rosenberg J, Hedderich J, Bein B, Hinz J, Hanss R. Investigation of the agreement of a continuous non-invasive arterial pressure device in comparison with invasive radial artery measurement. Br J Anaesth. 2012 Feb;108(2):202-10. doi: 10.1093/bja/aer394. Epub 2011 Dec 12.

    PubMed 22171358
  • Ilies C, Kiskalt H, Siedenhans D, Meybohm P, Steinfath M, Bein B, Hanss R. Detection of hypotension during Caesarean section with continuous non-invasive arterial pressure device or intermittent oscillometric arterial pressure measurement. Br J Anaesth. 2012 Sep;109(3):413-9. doi: 10.1093/bja/aes224. Epub 2012 Jul 12.

    PubMed 22798273
  • Gupta D, Soskin V, Marjanovic M, Amhaz H, Mazumdar A. CONTINUOUS NON-INVASIVE ARTERIAL PRESSURE DEVICE AS AN ADJUNCT TO RECOGNIZE FLUCTUATING BLOOD PRESSURES DURING ELECTIVE CESAREAN SECTION UNDER SUBARACHNOID BLOCKADE (SAB). Middle East J Anaesthesiol. 2016 Feb;23(4):385-400.

    PubMed 27382807
  • Hahn R, Rinosl H, Neuner M, Kettner SC. Clinical validation of a continuous non-invasive haemodynamic monitor (CNAP™ 500) during general anaesthesia. Br J Anaesth. 2012 Apr;108(4):581-5. doi: 10.1093/bja/aer499. Epub 2012 Feb 3.

    PubMed 22307242

Questions about this trial

What is this clinical trial studying?

An observational study of Pregnancy Related and Anesthesia, run by Asude AYHANt.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 1 inclusion and 9 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 1 Jul 2022. Status can change between updates, so confirm with the study contact before making plans.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Detection of hypoptensive episodes (time frame: Approximately 100minutes/patient (till the end of the C/S).). It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT05440695, which also lists 5 linked publications.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 1 Jul 2022; AzTrials last refreshed its copy on 1 Nov 2026.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in